A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma

MEYER, T ; KIRKWOOD, A ; MAYER, A ; GILLMORE, R ; O'BEIRNE, J ; PATCH, D ; BURROUGHS, A. K ; ROUGHTON, M ; BEARE, S ; TSOCHATZIS, E ; YU, D ; DAVIES, N ; WILLIAMS, E ; PEREIRA, S. P ; HOCHHAUSER, D

British journal of cancer, 2013-04, Vol.108 (6), p.1252-1259 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível